Arrayit Lands CDC Contract | GenomeWeb

NEW YORK (GenomeWeb News) – Arrayit said today that it has won a competitive contract from the Centers for Disease Control and Prevention for use of the company's microarray platform for biothreat response technologies.

The CDC will use the Arrayit microarray manufacturing platform to create microarrays for use in combating infectious agents, such as viruses and bacteria, which could be used in terrorist attacks.

Financial terms of the contract were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.